HuagongsheHuagongshe Chemistry Print Report · For research reference only
HCID 89442703, compound → 5-(2-(1-(6-amino-5-ethylpyrimidin-4-yl)piperidin-4-yl)-1-(2-(azetidin-1-yl)ethyl)-1H-imidazol-4-yl)-2-fluorobenzamide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | HCID 89442703 | HCID 89442703 | — |
| Reactant | 5-(1-(2-(azetidin-1-yl)ethyl)-2-(piperidin-4-yl)-1H-imidazol-4-yl)-2-fluorobenzamide | HCID 89442877 | — |
| Product | 5-(2-(1-(6-amino-5-ethylpyrimidin-4-yl)piperidin-4-yl)-1-(2-(azetidin-1-yl)ethyl)-1H-imidazol-4-yl)-2-fluorobenzamide | HCID 89442696 | — |
Reaction Steps
The title compound was prepared in an analogous manner as 6-(4-(1-(2-(azetidin-1-yl)ethyl)-4-(5-(trifluoromethyl)pyridin-3-yl)-1H-imidazol-2-yl)piperidin-1-yl)-5-ethylpyrimidin-4-amine of using 5-(1-(2-(azetidin-1-yl)ethyl)-2-(piperidin-4-yl)-1H-imidazol-4-yl)-2-fluorobenzamide instead of 3-(1-(2-(azetidin-1-yl)ethyl)-2-(piperidin-4-yl)-1H-imidazol-4-yl)-5-(trifluoromethyl)pyridine hydrochloride salt. LC-MS: (M+1=493, obsd.=493).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09145392B2 |
| Source dataset | uspto-grants-2015_09 |
| ORD ID | ord-748a349a4583422499c48663952e5f38 |
| Source note | uspto-grants-2015_09 |